MedPath

Exercise and immune change

Phase 2
Conditions
ot Patient- Healthy subjects, young athletes.
Registration Number
IRCT201111297255N3
Lead Sponsor
Investigator
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
10
Inclusion Criteria

Inclusion criteria included; having a history of at least 3 years of continuous and 8 hours per week of exercise endurance; maximal oxygen consumption 50 ml kg min; the absence of any disease of the immune system; vascular Kvrnr and infection in the past month; such as influenza; to colds; respiratory infections Hungarian; or symptoms such as fever; sore throat; runny nose; cough and other infectious diseases. The use of doping substances such as vitamins; dietary supplements; herbs or medications that affect the immune system are effective; Smoking and alcohol 48 hours before the test; Participate in heavy exercise; exposure to adverse environmental conditions; temperature; disease and viral infection during the plan period; were exclusion criteria.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Interleukin-17 Concentration. Timepoint: Before, immediately after and 2 h after exercise. Method of measurement: Using ELISA Kit.;CRP concentration. Timepoint: Before, immediately after and 2 h after exercise. Method of measurement: Using ELISA Kit.;IFN-?. Timepoint: Before, immediately after and 2 h after exercise. Method of measurement: Using ELISA Kit.
Secondary Outcome Measures
NameTimeMethod
ot have. Timepoint: Not have. Method of measurement: Not have.
© Copyright 2025. All Rights Reserved by MedPath